Skip to main content
OpenTrials
Completed

NCT Number: NCT02899689

Induction of Labor in Women With Unfavorable Cervix: Dilapan Versus Foley Bulb

Women undergoing mechanical cervical ripening for labor induction will be randomized to Dilapan-S® versus Foley bulb. The investigators hypothesized that osmotic cervical dilators (Dilapan-S®) are as effective as Foley bulb catheter in rates of vaginal delivery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

UTMB Galveston, Galveston, Texas, United States

Loading trial locations.

About this study

Historically, mechanical methods were the first methods developed to ripen the cervix or to induce labor. Dilapan-S® a synthetic osmotic cervical dilator made of a patented hydrogel (AQUACRYL), works by stimulating the release of endogenous prostaglandins, which degrade collagen fibers and soften the cervix. Additionally, it dilates the cervix gradually and the effect is gentle as well as predictable. Recently, Dilapan-S® has been approved by the FDA as a mechanical dilator for cervical ripening. There are no data comparing this newly approved Dilapan-S® to the Foley catheter, the most commonly used mechanical dilator method. Therefore, The investigators propose a randomized controlled trial to determine the efficacy of Dilapan-S® compared with Foley catheter for cervical ripening before induction of labor in pregnant women greater than 37 weeks.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant woman scheduled for induction of labor.
  • Age between 18 and 45 years.
  • Understanding and capable to sign informed consent.
  • Singleton pregnancy.
  • Gestational age ≥ 37 0/7 weeks.
  • Live fetus in cephalic presentation.
  • Intact membranes.
  • Pelvic exam (sterile vaginal exam) of less than or equal to 3cm and at most 60% effaced.

Exclusion criteria

  • Iodine allergy.
  • Active labor or oxytocin has been administered.
  • Chorioamnionitis.
  • Prior uterine or cervical surgery.
  • Non reassuring fetal status requiring immediate delivery.
  • Non-cephalic fetal presentation.
  • Active vaginal bleeding from cervical os.
  • Placenta previa.
  • EFW > 5000 gm(non diabetic) or > 4500gm (diabetic).
  • Other contraindication to vaginal delivery.

Treatment and study plan

Dilapan

Device

Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, synthetic osmotic dilators (Dilapan-S) are inserted into the cervical canal with special attention to cross through the internal os.

Other names: Osmotic cervical dilator

foley catheter

Device

Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, a Foley catheter is inserted into the cervix and the balloon is filled with 60 ml of sterile 0.9% NaCl.

Other names: Foley Bulb

Primary outcomes

  1. Rate of Vaginal Delivery

    Time frame: Through study completion, an average of 1-2 years

    Proportion of patients that delivered vaginal. (%)

Secondary outcomes

  1. Time of Vaginal Delivery

    Time frame: 2-4 days

    Delivery time frame in mins from cervical dilator insertion

  2. Time to Reach Active Stage of Labor as ≥ 6cm Cervical Dilation

    Time frame: 1-2 days

    time from hospital admission to reach active stage of labor defined as ≥ 6 cm (mins)

  3. Change in Bishop Scores

    Time frame: 12-24 hrs

    Change in Bishop score from insertion to extraction of device. The total score is calculated by assessing the following five components on manual vaginal examination by a trained professional: Cervical dilation in centimeters. Cervical effacement as a percentage. Cervical consistency by provider assessment/judgement.

    The highest possible score is 13 and the lowest possible score is 0. Bishop scores of less than 6 usually require that a cervical ripening method (pharmacologic or physical, such as a foley bulb) be used before other method

  4. Operative Deliveries

    Time frame: 1-4 days

    Proportion of patients that delivered vaginal by forceps assistance or vacuum (%) assistance.

  5. Cesarean Deliveries

    Time frame: 1-4 days

    Proportion of patients that delivered by cesarean (%).

Other outcomes

  1. Analgesia Requirement

    Time frame: 1-2 days

    Rate of women who require any analgesia used during insertion of the device

  2. Spontaneous Labor

    Time frame: 1-4 days

    Rate of women underwent spontaneous labor (%)

  3. Pharmacological Agents for Labor Induction (Prostaglandins, Oxytocin)(%)

    Time frame: 1-2 days

    Rate of women that required pharmacological cervical ripening agents (%) requirement (%)

  4. Artificial Rupture of Membranes (AROM)

    Time frame: 1-2 days

    Rate of women that had artificial rupture of membranes (AROM) (%)

  5. Regional Anesthesia

    Time frame: 1-2 days

    Rate of epidural/spinal analgesia (%)

  6. Device Insertion Time

    Time frame: 1-2 days

    Total duration of Dilapan-S® /Foley catheter insertion (mins)

  7. Device Placement to Delivery Interval

    Time frame: 1-4 days

    Interval from device placement to delivery (mins)

  8. Time After Mechanical Dilator

    Time frame: 1-2 days

    Induction (Oxytocin/Prostaglandin initiation) to delivery interval (mins)

  9. Comparison of Labor Curves Between Both Interventions

    Time frame: 1-2 days

    Labor curves using Kaplan Meier method comparing Dilapan-S to Foley balloon

  10. Device Complications

    Time frame: 1-2 days

    Rates of complications resulting from device insertion (%):

    Vaginal bleeding Vaso-vagal reaction from manipulation of the cervix Cervical laceration Retraction into the uterine cavity Rupture of membranes (Date/Time) Entrapment of the device Fragmentation of the device in the genital tract Rates of complications associated with cervical ripening(%) Uterine tachysystole/hypertonus Non reassuring fetal status Systemic adverse events (nausea, vomiting, diarrhea, fever, hypotension, tachycardia)

Sponsors and collaborators

Lead sponsor

The University of Texas Medical Branch, Galveston

Other

Collaborators

  • Medicem International CR s.r.o.

Registry information

Official study title

Induction of Labor in Women With Unfavorable Cervix: Randomized Control Study Comparing Dilapan to Foley Bulb

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Sep 14, 2016
Registry last updated
Nov 18, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.